In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. - Wikidata - wikimedia - TriplyDB

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33634302

about

Review of Journal of Cardiovascular Magnetic Resonance 2015 The role of magnetic resonance imaging in hypertrophic cardiomyopathy.Review of Journal of Cardiovascular Magnetic Resonance 2014.MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements.Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.Cardiac MRI: a central prognostic tool in myocardial fibrosis.Kinetic index combining native and postcontrast myocardial T1 in hypertrophic cardiomyopathy.Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.Changes in remote myocardial tissue after acute myocardial infarction and its relation to cardiac remodeling: A CMR T1 mapping study.Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Effect of contrast dose in the quantification of myocardial extra-cellular volume in adenosine stress/rest perfusion cardiac magnetic resonance examinations.3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.T1 mapping in children and young adults with hypertrophic cardiomyopathy.

P2860

Q28076518-97A10270-75CC-4533-ABDF-95B1865D572C Q30426380-E1282819-9993-4D2F-A858-166749527BAF Q30488573-5427AF2E-1798-44D5-A75E-C2E730B65FBE Q34481677-530D378A-0E5C-4137-AEEE-C27EBF7AC493 Q35655721-C55C43D3-D7BE-452E-83AD-1B27F93151EE Q36384508-A6DD8747-7E9D-4094-9A8E-D3746B8B6419 Q36851346-B427BB7F-2832-481D-B0DD-5A4392CDA56E Q38263089-88134E5E-61F4-40B5-AF72-D481BC529C88 Q38484413-5BEA71FF-29CA-4DB4-A7E9-E2AD1394C795 Q38769836-C3932118-6BB3-472F-8149-7CFB91CC9D9D Q40147991-8FB786CF-A169-4235-8B25-9C7B6DA5FADC Q42320941-5F633B0E-5AA5-4FD0-AF4F-778585EA7DE3 Q48951419-587BAEF3-FB0E-41DD-8D50-FB2717672F53 Q50585961-5C9E6144-2C05-492A-9FCC-E5BDBB8EE1FE Q51155770-DD896E65-A28E-48C8-BB4B-01D3CB8E1A04

P2860

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33634302

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@ast

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@en

type

label

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@ast

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@en

prefLabel

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@ast

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@en

P1433

Q33634302-E5215BD8-4C5C-47B3-83B4-025FBDF14200

P1476

Q33634302-F6DED31D-5E8B-42E7-8D18-A7A2C9D52B1C

P2093

Q33634302-27CBBC1D-A3BB-4311-95F5-34BE01391C4D

Q33634302-60BBC9C3-0401-4A1E-9974-B6B4AFD86DD8

Q33634302-63DB6ED1-67F9-42CC-9420-E239FD84A2AA

Q33634302-74289A62-D6EE-4FEF-85DB-CD5B49766AC2

Q33634302-9928707D-0065-43C8-BC08-073DADC84991

Q33634302-AB4F3433-0985-4F8C-ABCE-45BF6834740D

Q33634302-FFEDD58C-3D33-4354-B751-A64128CF21EA

P2860

Q33634302-06A9817F-8423-4E86-ADEC-6A6C2F3B1E7B

Q33634302-0FB2506D-C650-47E5-9AE3-7327B834372E

Q33634302-1168DADA-8B4E-498C-884E-6E31017AC219

Q33634302-11DCC4C3-492E-497A-983A-F3B30AA2BEAF

Q33634302-157FCDFD-2BD5-4E4C-B3EC-B6C3121288C5

Q33634302-644758F4-72A0-430E-90D4-55E26CE1081D

Q33634302-679CC7A9-F6BB-4055-98E6-C7C143D000CA

Q33634302-6CFCC0D2-2E54-4168-8731-1DE5BD4579D9

Q33634302-7AAC4A68-5427-4E23-A5DF-B81880E13C00

Q33634302-8459EEEE-F643-458B-B660-711B63449393

P2888

Q33634302-DCA69EE8-0598-44B4-8C42-A1B224B25FA2

P304

Q33634302-8681955D-6C7E-4A6C-A4B1-01C3D413E9CD

P31

Q33634302-7FA6198E-3505-4674-9AD0-9AF17BE460CF

P356

Q33634302-377868B2-866A-43A2-9033-6244AA802A93

P478

Q33634302-A9972B29-D994-4365-88F2-1DF5575740CD

P50

Q33634302-2DCD672A-8D15-4C9A-AB5B-A541ED21415C

P577

Q33634302-437ED60D-DA26-4DF7-83F9-6B465B02798C

P5875

Q33634302-7705C024-242B-4B38-8575-B4BF57124F29

P6179

Q33634302-7387A8E0-5F7E-4DEA-8916-C7EE3EA52905

P698

Q33634302-164C6EEB-0E13-4CE5-ADE3-EC57F6FC2467

P921

Q33634302-BABE9FA7-94D6-42C4-A826-4FC343BE0C91

P932

Q33634302-DFB8712F-2D7A-44FF-AE1A-F6B2122074EE

P356

1532-429X-16-28

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

In-vivo T1 cardiovascular magn ...... n hypertrophic cardiomyopathy.

@en

P2093

Aernout M Beek

http://www.w3.org/2001/XMLSchema#string

Albert C van Rossum

http://www.w3.org/2001/XMLSchema#string

Emma N Baars

http://www.w3.org/2001/XMLSchema#string

Karin de Boer

http://www.w3.org/2001/XMLSchema#string

Mark B M Hofman

http://www.w3.org/2001/XMLSchema#string

Tjeerd Germans

http://www.w3.org/2001/XMLSchema#string

Wessel P Brouwer

http://www.w3.org/2001/XMLSchema#string

P2860

An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease.

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart.

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Hypertrophic cardiomyopathy: a systematic review.

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

P2888

1532-429x-16-28

P304

28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1532-429X-16-28

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Jolanda van der Velden

P577

2014-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261915898

http://www.w3.org/2001/XMLSchema#string

P6179

1041346641

http://www.w3.org/2001/XMLSchema#string

P698

24766828

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4026831

http://www.w3.org/2001/XMLSchema#string